Advanced Glycation End Products Upregulate Insulin Receptor Substrate-1 (IRS-1) in Human Cumulus Granulosa Cells
Zaher Merhi · 2026
Read Advanced Glycation End Products Upregulate Insulin Receptor Substrate-1 (IRS-1) in Human Cumulus Granulosa Cells by Zaher Merhi (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13359921.txt.
Description
Zaher Merhi studies sugar-damaged proteins and ovarian insulin resistance in a 2026 paper. Women with polycystic ovary syndrome often show high levels of advanced glycation end products, compounds formed when sugar sticks to proteins. These build up in the ovaries and may disturb insulin signaling in the cells that nurse the egg. Merhi tested that idea in human cumulus granulosa cells from IVF patients.
Cells fed the glycated protein raised the gene for its receptor more than threefold and the gene for an insulin signaling protein, IRS-1, more than fourfold. The results support the theory that these compounds help drive ovarian insulin resistance in the syndrome.
Catalog record
| CREATOR | Zaher Merhi |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 25874 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |